NEW YORK, NY / ACCESSWIRE / July 31, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in L Brands, Inc. (“L Brands” or the “Company”)(NYSE:LB) of the September 23, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in L Brands stock between May 31, 2018 and November 19, 2018 and would like to discuss your legal rights, click here: www.faruqilaw.com/LB. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Southern District of Ohio on behalf of all those who purchased L Brands common stock between May 31, 2018 and November 19, 2018 (the “Class Period”). The case, Walker v. L Brands, Inc. et al., No. 19-cv-03186 was filed on July 23, 2019, and has been assigned to Judge Sarah D. Morrison.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that L Brands’ Victoria’s Secret and PINK businesses began to experience deteriorating operating performance due to, among other things, increased competition from new lingerie brands.

Specifically, in an attempt to drive sales and retain market share in the face of increasing competition, Victoria’s Secret and PINK engaged in heavy promotional activities by offering consumers large discounts and even giving items free of charge. While this marketing strategy helped to mitigate sales declines, it adversely impacted the Company’s profit margins and cash flows and had a deleterious impact on the Company’s liquidity. In response to questions from securities analysts about the sustainability of the Company’s dividends, defendants repeatedly stated that L Brands had sufficient cash flow and cash on hand to sustain its dividends and that the Company, “in its history, ha[d] never reduced the dividend.”

Then, after the market closed on November 19, 2018, L Brands issued a press release announcing its financial results for the 2018 third quarter ending on November 3, 2018. The press release also announced that L Brands intended to reduce its annual ordinary dividend to $1.20 from $2.40 beginning with the quarterly dividend to be paid in March 2019 in order to deleverage.

On this news, L Brands’s share price fell from $34.55 per share on November 19, 2018 to a closing price of $28.43 on November 20, 2018: a $6.12 or a 17.71% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding L Brands’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 554128

NEW YORK, NY / ACCESSWIRE / July 31, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Merit Medical Systems, Inc.(“Merit” or the Company”) (NASDAQ:MMSI). Investors who purchased Merit securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/mmsi.

The investigation concerns whether Meritand certain of its officers and/or directors have violated federal securities laws.

On July 25, 2019, post-market, Merit announced its financial and operating results for the second quarter of 2019. The Company announced net income of $6.9 million, or $0.12 per share, compared to $10.9 million, or $0.21 per share for the same period in the prior year. Merit’s Chairman and Chief Executive Officer, Fred P. Lampropoulos, cited “a number of factors affecting revenues and gross margins during the second quarter,” including “foreign exchange [and] slower than anticipated conversion and uptake of acquired products.” On this news, Merit’s stock price fell $13.84 per share, or 25.24%, to close at $41.00 on July 26, 2019.

If you are aware of any facts relating to this investigation, or purchased Merit shares,you can assist this investigation by visiting the firm’s site: www.bgandg.com/mmsi. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcome.

CONTACT:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 554148

If your child wandered off at the mall or the beach, could he or she be identified?

ROCKVILLE, MD / ACCESSWIRE / July 31, 2019 / Child ID, an online ID card service, now offers an effective way to confirm a child’s identity and provide the guardian’s contact info.

Its photo ID cards for kids offer a simple way for a lost child to be identified and also give important information to caregivers. Made from the same durable PVC plastic as credit cards, they resist bending, scratching and liquids.

The parent or guardian chooses a template on the Child ID website and enters the required information (child’s name, guardian’s name, and guardian’s contact information) plus optional information such as date of birth, height, weight, blood type, and allergies, and uploads a photo. Special cards for children with a heart condition or autism are available.

Bag tags are also available. These are simplified IDs with slot punches that can be attached to backpacks, cubbies or clothing.

The cost is $9.95 per card, including prompt shipping, from https://child.idcardsonline.net.

More than 464,000 missing-children reports were filed with authorities in 2017. Many of these frightening incidents can be avoided by having children carry contact information at all times.

Besides the child, it makes sense to give copies to babysitters-so that they have key information handy-and teachers, who will have a durable record of the child’s needs and medical information. For parents, keeping the ID in their wallets ensures they always have a durable up-to-date photo of their child at all times.

Having medical information always handy is crucial for children with conditions such as severe food or bee-sting allergies. It could potentially make the difference between life and death.

Child ID is a new offering from InstantCard. Since 2007, InstantCard has been America’s first 100 percent web-based employee photo ID card service. Using cloud-based technology, InstantCard creates ID cards quickly, easily and cost-effectively. Trustpilot gives InstantCard a five-star “excellent” rating.

Child ID card can include detailed medical and identity info.

Example of Child ID with basic info only.

Contact: Henry Stimpson, Stimpson Communications, 508-647-0705, Henry@StimpsonCommunications.com

SOURCE: InstantCard

ReleaseID: 554109

NEW YORK, NY / ACCESSWIRE / July 31, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Heron Therapeutics, Inc. (NASDAQ:HRTX)
Class Period: October 31, 2018 to April 30, 2019
Lead Plaintiff Deadline: August 5, 2019

During the class period, Heron Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Heron had failed to include adequate Chemistry, Manufacturing, and Controls (“CMC”) and non-clinical information in its NDA for HTX-011; (ii) the foregoing increased the likelihood that the FDA would not approve Heron’s NDA for HTX-011; and (iii) as a result, Heron’s public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in HRTX: http://www.kleinstocklaw.com/pslra-1/heron-therapeutics-inc-loss-submission-form?id=2696&from=1

Pivotal Software, Inc. (NYSE:PVTL)
Class Period: investors who purchased common stock pursuant or traceable to the April 2018 initial public offering and/or Pivotal securities between April 24, 2018 and June 4, 2019.
Lead Plaintiff Deadline: August 19, 2019

According to the complaint, Pivotal Software, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Pivotal was facing major problems with its sales execution and a complex technology landscape; (ii) the foregoing headwinds resulted in deferred sales, lengthening sales cycles, and diminished growth as its customers and the industry’s sentiment shifted away from Pivotal’s principal products because the Company’s products were outdated, inadequate, and incompatible with the industry-standard platform; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in PVTL: http://www.kleinstocklaw.com/pslra-1/pivotal-software-inc-loss-submission-form?id=2696&from=1

Intelligent Systems Corporation (NYSE:INS)
Class Period: January 23, 2019 to May 29, 2019
Lead Plaintiff Deadline: September 9, 2019

The complaint alleges Intelligent Systems Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) Defendant Petit, the “financial expert” on the Company’s Audit Committee, engaged in accounting fraud as the CEO of MiMedx Group; (2) the Company’s CEO, Defendant Strange, engaged in undisclosed related-party transactions with Defendant Petit and others and had an undisclosed personal relationship with the Company’s auditor; (3) the Company had its employees set up or take control of shell companies in Asia so they could partake in undisclosed related-party transactions for the purpose of either fabricating revenue for the Company and/or siphoning money out of the Company; and (4) as a result, Defendants’ statements about Intelligent Systems’ business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in INS: http://www.kleinstocklaw.com/pslra-1/intelligent-systems-corporation-loss-submission-form?id=2696&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 554149

LOS ANGELES, CA / ACCESSWIRE / July 31, 2091 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Box, Inc. (“Box” or “the Company”) (NYSE: BOX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between November 28, 2018 and June 3, 2019, inclusive (the “Class Period”), are encouraged to contact the firm before August 5, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Box failed to close large deals within the quarter. The failure to close important deals materially impacted the Company’s revenue. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Box, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 554141

LOS ANGELES, CA / ACCESSWIRE / July 31, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against L Brands, Inc. (“L Brands” or “the Company”) (NYSE: LB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between May 31, 2018 and November 19, 2018, inclusive (the ”Class Period”), are encouraged to contact the firm before September 23, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. L Brands’ Victoria’s Secret and PINK stores experiencing worsening performance due in part to competing lingerie brands. The Company worked to drive sales through heavy promotional efforts such as offering customers discounts and free items. Although these tactics helped L Brands fight declines in sales, they impacted profit margins and cash flow negatively, also hurting the Company’s liquidity. When asked by market analysts about the sustainability of the Company’s dividend, executives replied that the Company “in its history, ha[d] never reduced the dividend.” Just weeks later, L Brands announced it was cutting its dividend in half to pay down debts. On this news, shares of L brands dropped by 18% on November 20, 2018. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about L Brands, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 554142

NEW YORK, NY / ACCESSWIRE / July 31, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Box, Inc. (NYSE:BOX)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/box-inc-loss-submission-form?prid=2695&wire=1
Lead Plaintiff Deadline: August 5, 2019
Class Period: November 28, 2018 to June 3, 2019

Allegations against BOX include that: (1) the Company was unable to close large deals within the quarter; (2) that, as a result, the Company’s revenue would be materially impacted; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Zuora, Inc. (NYSE:ZUO)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/zuora-inc-loss-submission-form?prid=2695&wire=1
Lead Plaintiff Deadline: August 13, 2019
Class Period: April 12, 2018 to May 30, 2019

Allegations against ZUO include that: (1) the Company would focus on implementing RevPro for new customers ahead of the deadline to comply with accounting standard ASC 606; (2) as a result, the Company lacked adequate resources to integrate RevPro with the core business; (3) the Company would focus on RevPro integration a year after the acquisition closed; (4) delays in integrating RevPro would materially impact the business; (5) the market for RevPro was limited to customers seeking to implement new accounting standards such as ASC 606; (6) after the deadline for ASC 606 compliance passed, demand for RevPro was reasonably likely to decline; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Eagle Bancorp, Inc. (NASDAQCM:EGBN)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/eagle-bancorp-inc-loss-submission-form?prid=2695&wire=1
Lead Plaintiff Deadline: September 23, 2019
Class Period: March 2, 2015 to July 17, 2019

Allegations against EGBN include that: (i) Eagle Bancorp’s internal controls and procedures and compliance policies were inadequate; (ii) the foregoing shortcoming created a foreseeable risk of heightened regulatory scrutiny and the need for the Company undertake its own internal investigations; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 554136

NEW YORK, NY / ACCESSWIRE / July 31, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Mallinckrodt plc (“Mallinckrodt” or the “Company”) (NYSE:MNK) of the September 24, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Mallinckrodt stock or options between February 28, 2018 and July 16, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/MNK. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Mallinckrodt Avalanche securities between February 28, 2018 and July 16, 2019 (the “Class Period”). The case, Strougo v. Mallinckrodt Public Limited Company, No. 1:19-cv-07030 was filed on July 26, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making materially false and/or misleading statements and/or failing to disclose that: (1) Acthar posed significant safety concerns that rendered it a non-viable treatment for ALS; (2) accordingly, Mallinckrodt overstated the viability of Acthar as an ALS treatment; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Specifically, on July 16, 2019, post-market, Mallinckrodt announced that the Company was permanently discontinuing the PENNANT Trial, assessing Acthar’s safety and efficacy as an ALS treatment. Mallinckrodt stated that it decided “to halt the trial after careful consideration of a recent recommendation by the study’s independent Data and Safety Monitoring Board” (“DSMB”), which “was based on the specific concern for pneumonia, which occurred at a higher rate in the ALS patients receiving Acthar Gel compared to those on placebo” and that “the board also mentioned other adverse events specific to this patient population.”

On this news, Mallinckrodt’s stock price fell from $8.20 on July 16, 2019 to $7.56 on July 17, 2019-a $0.64 or a 7.80% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Mallinckrodt’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 554127

NEW YORK, NY / ACCESSWIRE / July 31, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diebold Nixdorf, Incorporated (“Diebold” or the “Company”) (NYSE:DBD) of the September 3, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Diebold stock or options between May 4, 2017 and July 4, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/DBD. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Diebold securities between May 4, 2017 and July 4, 2017 (the “Class Period”). The case, Karp v. Diebold Nixdorf, Incorporated et al., No. 19-cv-06180 was filed on July 2, 2019, and has been assigned to Judge Loretta A. Preska.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that the Company was experiencing delays in systems rollouts negatively impacting the Company’s services business and operations.

On July 5, 2017, Diebold issued a press release titled “Diebold Nixdorf Adjusts 2017 Financial Outlook”. The press release disclosed that the Company expected a wider net loss than indicated in its prior guidance for fiscal 2017, from a range of $50 to $75 million to a range of $110 to $125 million net loss. Diebold attributed the lowered expectations to a delay in systems rollouts as well as a longer customer decision-making process and order-to-revenue conversion cycle.

On this news, Diebold’s share price fell from $28.00 per share on July 3, 2017 to a closing price of $21.60 on July 5, 2017: a $6.40 or a 22.86% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Diebold’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 554126